3,3′-disubstituted indolines as inhibitors of cholesterol ester transfer protein
US9688630B2 · kind B2 · utility
0Cited by
16References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 6, 2014 |
| Grant date | Jun 27, 2017 |
| Priority date | — |
| Expiry date | Oct 6, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/107
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
3,3′-Disubstituted indoline compounds, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.